International Assets Investment Management LLC increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 6,397.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 100,000 shares of the exchange traded fund’s stock after purchasing an additional 98,461 shares during the quarter. International Assets Investment Management LLC’s holdings in SPDR S&P Biotech ETF were worth $15,768,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of XBI. Axiom Investment Management LLC acquired a new position in SPDR S&P Biotech ETF in the 1st quarter worth approximately $26,000. Angeles Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $28,000. Root Financial Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $31,000. Morling Financial Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $36,000. Finally, Ascentis Independent Advisors acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter worth $42,000.
SPDR S&P Biotech ETF Price Performance
NYSEARCA:XBI opened at $155.98 on Friday. The company’s fifty day moving average price is $156.60 and its 200-day moving average price is $141.58. SPDR S&P Biotech ETF has a 1-year low of $106.30 and a 1-year high of $169.89. The firm has a market capitalization of $10.72 billion, a P/E ratio of 11.47 and a beta of 0.83.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Starbucks Says Its Turnaround Is DoneāThe Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
